ENTITY

SAI Life Sciences (SAILS12 IN)

32
Analysis
Health Care • India
SAI Life Sciences Limited develops pharmaceuticals. The Company focuses on drug and active ingredient discovery, development, and manufacturing. SAI Life Sciences manages research facilities worldwide.
more
•06 Oct 2026 07:42•Broker

Monthly Quant Report October 2026

Global central banks remain in a data-dependent, wait-and-watch posture following recent rate hikes from the Fed and ECB...

Logo
86 Views
Share
•05 Aug 2026 07:56

Primer: SAI Life Sciences (SAILS12 IN) - Aug 2026

SAI Life Sciences is a rapidly growing, fully integrated Contract Research, Development, and Manufacturing Organization (CRDMO) providing...

Logo
99 Views
Share
•10 Apr 2026 09:03•Broker

Pharma and Healthcare (Q4FY26E Results Preview): Steady revenue growth, margins pressure visible

Our assumptions are: (1) Pharma coverage will see 10% YoY sales growth driven by 15% YoY increase in the India business (ex-Torrent + JB growth at...

Logo
155 Views
Share
•07 Apr 2026 08:56•Broker

Pharmaceuticals: US tariffs on branded drugs, generics exempted

We believe the key motive behind tariffs is to push the innovator company toward MFN or investment in plants/R&D to bring down drug prices.

Logo
163 Views
Share
•30 Mar 2026 15:11

India's Guided Growth Playbook: 20 Companies Telling You Exactly Where They're Going

​These are 20 Indian Companies offering specific, multi-metric guidance signal confidence and accountability in a market dominated by execution risk.

Logo
296 Views
Share
x